Manuel Román
About
In The Last Decade
Manuel Román
108 papers receiving 1.8k citations
Peers
Comparison fields: 5 of 118
- Pharmacology 544
- Immunology 455
- Psychiatry and Mental health 300
- Oncology 287
- Pediatrics, Perinatology and Child Health 274
Countries citing papers authored by Manuel Román
This map shows the geographic impact of Manuel Román's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Manuel Román with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Manuel Román more than expected).
Fields of papers citing papers by Manuel Román
This network shows the impact of papers produced by Manuel Román. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Manuel Román. The network helps show where Manuel Román may publish in the future.
Co-authorship network of co-authors of Manuel Román
This figure shows the co-authorship network connecting the top 25 collaborators of Manuel Román. A scholar is included among the top collaborators of Manuel Román based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Manuel Román. Manuel Román is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | 0 | |
| 3 | 5 | |
| 4 | 6 | |
| 5 | Bilastine 0.6% once-daily, preservative-free eye drops pharmacokinetics after single and multiple dose administration | 1 |
| 6 | 19 | |
| 7 | 19 | |
| 8 | Resistencia antimicrobiana en aislados clínicos de Pseudomonas aeruginosa | 3 |
| 9 | 44 | |
| 10 | Investigación de las resistencias a antimicrobianos en Enterococcus faecalis | 7 |
| 11 | Situación de las resistencias a fármacos de Mycobacterium tuberculosis en España | 23 |
| 12 | Sensibilidad y resistencia de Pseudomonas aeruginosa a los antimicrobianos | 6 |
| 13 | Sensibilidad a los antimicrobianos de Enterococcus faecalis aislados de pacientes en la provincia de Córdoba (España) | 3 |
| 14 | 2 | |
| 15 | Microorganismos aislados de muestras de orina procedentes de la comunidad y patrón de sensibilidad en un periodo de 12 años | 4 |
| 16 | El virus de la hepatitis C como patógeno emergente II: epidemiología y vías de transmisión | 1 |
| 17 | Sensibilidad a antimicrobianos de los aislamientos bacterianos de pacientes con fibrosis quística | 5 |
| 18 | 1 | |
| 19 | Contribución al estudio epidemiológico de las dermatofitosis en Córdoba (1994-1996). | 1 |
| 20 | 5 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.